KRAS and lung cancer: The most direct evidence of an anti-lung cancer role for NK cells comes from Kras-driven spontaneous lung cancer and cancer cell-injection experiments in mice, in which mice lacking NK cells were generated by Nfil3 knockout or administration of antibodies against NK1.1 or asialo-GM1.